News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal
Naveen Pemmaraju and Hannah Goulart
May 6, 2025, 17:55

Naveen Pemmaraju shares new report on oral DAC+VEN for BPDCN published in Leukemia and Lymphoma Journal

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared an article co-authored by Hannah Goulart et al. on LinkedIn:

“Delighted to share our brand new original report  just published in Leukemia and Lymphoma, led by Dr Hannah Goulart and Dr Naveen Pemmaraju, MD oral DAC+VEN for patients with BPDCN”

Title: A case series of oral decitabine–cedazuridine with venetoclax for blastic plasmacytoid dendritic cell neoplasm

Journal: Leukemia and Lymphoma

Authors: Hannah Goulart, Guillermo Garcia-Manero, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Farhad Ravandi, Muzaffar Qazilbash, Caitlin Rausch, Gabriela Llaurador Caraballo, Sherry Pierce, Naveen Pemmaraju

Read the full article.

Naveen Pemmaraju

Learn more about blastic plasmacytoid dendritic cell neoplasm on OncoDaily.

Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN Caitlin Rausch cancer Courtney D. DiNardo Farhad Ravandi Gabriela Llaurador Caraballo Guillermo Garcia-Manero Hannah Goulart MD Anderson Cancer Center Muzaffar Qazilbash Naval Daver Naveen Pemmaraju OncoDaily Oncology Sherry Pierce Tapan M. Kadia
Special Coverage
Blog
Jul 9, 2025, 04:05
Community Tribute Film: Voices from Across Africa - Pan-African PGS Education and Research Initiative
Blog
Jul 9, 2025, 01:52
Zoë Mullan: Hope to See Some Familiar Faces at 2025 Asian Conference on Implementation Science
Insight
Jul 9, 2025, 01:44
Inhibiting CDS2 Selectively Kills CDS1-deficient Cancer Cells - The Netherlands Cancer Institute
Blog
Jul 8, 2025, 20:46
Experts Driving Innovation in Radiation Oncology Through the ESTRO Focus Group
Blog
Jul 8, 2025, 20:27
Abdu Adem Yesufe: Immensely Grateful for IAEA's Support Thus Far
Blog
Jul 8, 2025, 20:24
Svetlana Nikic: Honored to Attend HBA and Almirall Event on Women’s Development
Blog
Jul 8, 2025, 20:03
Alfredo Addeo: Colloquiums of the Department of Medicine in HUG Presented a Fascinating Conference
Blog
Jul 8, 2025, 19:47
A Webinar on "Overcoming Barriers to Pediatric Cancer Care in Nepal" on July 17 - The Max Foundation
Blog
Jul 8, 2025, 19:34
Edward Cliff: A Short Taster of Our Session to the Video Journal of Hematology and Hematological Oncology
Drugs
Jul 8, 2025, 18:55
Miguel Bronchud: Who Pays for New Drugs?
Blog
Jul 8, 2025, 18:45
Women With Overweight/Obesity and a History of CVD are 31% More Likely to Develop Breast Cancer - IARC
Blog
Jul 8, 2025, 18:08
A New Report on Ethnic Inequalities in Cancer Care - European Cancer Organisation